Statement on Drug User Fees: Enhancing Patient Access and Drug Safety

March 14, 2007
KimWitczakWrittenStatement
46.2 KB

Transparency and openness is the key to restoring the FDA as the world’s ‘gold standard’ in drug approvals and safety.

IssuesHealth
You Might Also Be Interested In
press release
November 23, 2020
Consumer Reports Renews Call For Mandatory COVID-19 Safety Standards For Airlines and Airports As Holiday Travel Season Begins
November 13, 2020
Consumer Reports letter to Senate Commerce Committee opposing S 4613, Contact Lens Rule Modernization Act
October 16, 2020
Joint amicus brief in defense of California law prohibiting anti-competitive generic drug pay-for-delay deals
September 8, 2020
CR comments to Copyright Office supporting renewal of pro-consumer exemptions from section 1201 of Digital Millennium Copyright Act